1406
HLAVNÍ42522701005185134178232252
TÉMA69222701003981147194
Osteoporóza42533701004777104139179217256281319350385
u826337010037
premenopauzálnych8793370100376297157192230269307342380412447463500536566604
žien14993370100304681119
29018622701003679124
|326227010043
VNITŘNÍ4268043010746106127172220280301
LÉKAŘSTVÍ748804301074185130188236280325378400
/11688043010757
Vnitř12458043010771118137165191
Lék1456804301074083122
2021;1597804301074487129168178
67(5):1794804301074486106148171185
284–2901999804301074486132180219262308
/23268043010757
www.casopisvnitrnilekarstvi.cz442680430107651332012142542953293774274464795215705896176436927117307748128548809159449871007102310631101
8.4255530853652
Dutta4925540834684107131164
D67155408346
et7325540833456
al.804554083324760
Occurrence8795540834880111149170192226264296330
&122455408339
predictors1279554083396094134149181205242264291
of15855540833857
osteoporosis1657554083386488121160200239260297324339365
&203755408340
impact20925540831573112145177201
of23085540833857
body23805540833978118150
composition25455540833168127166205231246269284322360
alterations425654083324770103125158179195233271297
on7386540834079
bone8326540834281119154
mineral10026540836075113148169202218
health12356540834176108123146184
in14346540831856
asymptomatic1505654083356294153192214251309342363379411
pre-menopausal1931654083426498121179215253291331363401427461476
women24226540835492150185223
with2661654083536991130
HIV2806654083476399
infection.425754083155371106139163178216254268
The7087540833272107
Indian830754083155392107139177
journal1022754083155391113151184199
of12367540833757
medical13087540835793132147179212227
research,1551754083205481116148169200238251
2018;18177540833569100131144
147(5):1976754083346597114147166177
p.21697540833851
484–495.22357540833470107144181214248260
9.4258530853650
Cairoli491854083457994116153170185
E69285408338
et7468540833962
al.824854083375366
Bone9068540834180119154
involvement1076854083205991129145178213272307346368
in14608540832058
young15348540833675113152192
adults17418540833877116131154182
with1939854083567295134
cystic2089854083377198122137170
fibrosis2275854083223979101139166181208
awaiting24988540833889123138161177215255
lung2768854083215997137
transplantation425954083224376113140178194226264285318340355392431
for871954083165375
end-stage9619540833169108130157180213251286
respiratory1262954083195279118133154187209245267301
failure.157895408316496479116137171183
Osteoporos1776954083457295128167206245266303330
Int,212195408312507285
2019.2221954083326597127138
30(6):2374954083326686119137148
p.25389540833648
1255–1263.2601954083326296129165195225259292305
10.4251053085367085
Martínez-Morillo52510540835588109134149187222252273329368389405420435473
MD.1014105408355101112
Grados,11411054083456699138176203216
and137210540833371110
S.149710540833347
Holgado,15591054083458399138170209247259
Premenopausal18341054083365690148183221260299332370396429445
Osteoporosis:22941054083487598131170210249270307334349375388
How269710540834583134
to284610540832360
Treat?4251154083335084116137163
Reumatología60311540833671108166199220257273311351366398
Clínica10161154083405570108123155188
(English12201154083185189128143158184222
Edition),14571154083337186109124162200218229
2012;170111540833469100130143
8(2):18591154083345387105117
p.199111540833951
93–97.205811540833467103138171177
11.4251253085366678
Weaver51812540835589120152186208
CM74112540833793
et84912540833254
al.9181254083304558
The99112540833170105
National11111254083427597112150188221236
Osteoporosis13621254083457295129168207246268305332346373
Foundation’s175012540833067105143182215236252290328340365
position213112540833877104119141156194233
statement23791254083244780102135193228267288
on268212540833574
peak277112540833672104134
bone42513540833977116151
mass59113540836092119146
development75213540834075108142157196235293328367388
and115513540833573112
lifestyle1282135408317325286113136170186221
factors:15181354083215486110147169196209
a1742135408334
systematic17921354083265885108142200232254269301
review21091354083235789105140191
and231513540833472111
implementation244213540831775114130164222257295317350372387425463
recommendations.4251454083215587124183240275314353385407422460498525538
Osteoporos9791454083477497131169209248269307333
Int,1328145408314527487
2016;143014540833569100132144
27(4):15891454083346784117134146
p.175014540833951
1281–1386.18171454083346498129162193223258293306
12.4251553085366884
Schousboe52415540833567105144182208247286321
JT86115540832661
et93715540833658
al.10111554083344962
Executive108815540833568102135172195210243277
summary138015540832966124182214235269
of166515540833958
the17391554083246297
2013185115540833771103132
International19991554083175576110131170202224239277316348363
Society237815540833573106121155178211
for26051554083205880
Clinical27001554083425772110125157190205
Densitometry42516540834681120146161184221280316338360394
Position83516540834077104119142157196235
Development108516540835187119154170208248307342381402
Conference150316540834583121140175197231270302336
on185516540834281
bone195216540834483122157
densitometry.212516540834378117143158181218277312335357391401
J2542165408329
Clin25871654083456076114
Densitom,27161654083518712515216742517540832259117130
2013;57017540833468100130141
16(4):7271754083346584117134146
p.88917540833851
455–466.9551754083346799136173209244258
13.4251853085366883
Shepherd52318540833472107146185220241279
JA81818540832565
et89818540833658
al.9721854083334861
Executive104818540833467101134171194209242276
Summary133918540833472130187220241275
of162918540833958
the17031854083236196
2015181418540833670102132
ISCD19611854083164989135
Position211118540833773100115137153191229
Development235518540834782115149165203242301336374395
Conference2766185408341781164251954083185374108146178212
on65219540834078
Advanced74519540834382114147185217251291
Measures105119540835691123150187208242269
From13351954083355492150
DXA150019540834885127
and164319540833372111
QCT:176919540834990126134
Fracture19181954083355587120144182203237
Prediction21701954083375892132147179203218256295
Beyond248019540833772104142180219
BMD.271419540833893139150
J2879195408326
Clin4252054083405570108
Densitom,54820540834681119145160183220278291
2015;85420540833468100130141
18(3):10102054083346584118135147
p.117220540833951
274–286.12392054083346797135166200235249
14.4252153085356883
Greendale5232154083416295130167206237252286
GA82421540834182
et92121540833153
al.9882154083294457
Bone106021540833270107142
mineral121721540835468106140161193208
density144021540833569106132146168201
loss16562154083125076102
in177321540831249
relation1837215408318516698119134171209
to206121540831855
the21312154083185690
final22362154083143168100115
menstrual236521540835589126152175196233265280
period26602154083357091106143182
in285721540831249
a425225408332
multiethnic47222540835694109131146180202240277292323
cohort:81122540832864103140162186199
results10252254083185278115130152179
from12202254083153774132
the13672254083195691
Study14732254083305088127158
of164622540833554
Women’s171522540835490148183220232257
Health198722540834378109124146184
Across21862254083386990127154180
the23812254083195791
Nation24872254083427495110148186
(SWAN).268822540831647105144188207217
J425235408324
Bone46423540833674113148
Miner62723540835570108143164
Res,8062354083367198111
2012;93223540833468100130142
27(1):10902354083346783115129141
p.124623540833952
111–118.13132354083346289122153181212225
15.4252453085366882
Ferrari5222454083306485106139160175
S712245408330
et75724540833456
al.8282454083294457
Osteoporosis9002454083447194127166205243265301328342368
in128324540831350
young134824540832866103141180
adults:154324540832968105120142169182
pathophysiology,17402454083366890128166205243273300315352368406445477486
diagnosis,22412454083365182121159197223238263276
and253224540833067106
management.26532454083558712415619522942525540835792130152165
Osteoporos6062554083477497131169209248269307333
Int,955255408314527487
2012;105725540833569100130143
23(12):12152554083346987119149167178
p.140925540833851
2735–2748.147525540833467102135171202235266302315
16.4252653085366985
Lewiecki52526540833064115131165198228245
EM78526540833186
et88626540833255
al.9562654083304558
Proceedings10302654083335491123157193232247285324350
of139626540833554
the14662654083205893
201615742654083326698129
Santa171926540833063101123156
Fe189026540833165
Bone197026540833372110145
Symposium:213126540833060119158197223238276334346
New249226540834378129
Concepts263626540833976114146180219241269
in42527540831452
the4922754083195691
Management59827540835183120152191225282317354375
of98827540833453
Osteoporosis10562754083447194127165204242263300326340366
and143727540832967105
Metabolic155727540835186108140178217232247278
Bone185027540833371108143
Diseases.20082754083425783117149175209236249
Journal22722754083215996117155187202
of248927540833453
Clinical25572754083375266104118150182197
Densitometry,2769275408342771154252854083264163100159194216237271281
2017;72228540833468100129139
20(2):8762854083346888122140152
p.104328540833951
134–152.110928540833564100137168198231244
17.4252953085366876
Lewiecki51729540833367119134169202232248
EM78029540833590
et88529540833658
al.9582954083344962
International10352954083175576110131170202224239277315348363
Society141329540833573106121155178211
for16402954083205779
Clinical17342954083425772110125157190205
Densitometry195429540834782121147162184221279314337358392
2007236229540833569106138
Adult251529540834381119134157
and268729540833371110
Pediatric2813295408336704253054083385385107128144176
Official6163054083476785103135150182197
Positions.8293054083357198113135151189227253267
Bone,111130540833674113148160
2008;128630540833468104140152
43(6):14533054083346785118136148
p.161730540833851
1115–1121.16833054083346290120156187215244276285
18.4253153085366985
Buckley52631540834179111141158192224
L765315408337
et81731540833961
al.8943154083375265
201797431540834074105135
American1124315408346104139161176208241279
College14193154083458298113148187222
of165631540834362
Rheumatology173331540834179114152210242264301317355395427
Guideline217531540834987102141176192207245280
for24703154083236183
the256831540832765100
Prevention268331540834061951281622004253254083223775113
and55432540833674113
Treatment6823254083375488120142200235273294
of99232540834160
Glucocorticoid-Induced106832540834763101133170203240261286301333370385424447463501540578610644683
Osteoporosis.176632540835178102135174214253274311338353379393
Arthritis21743254083456691129150166188204230
Rheumatol,241932540833978113151208241263299315328
2017;276232540833872104134143
69(8):4253354083346887121139151
p.59133540833951
1521–1537.6583354083346497128161192222255287293
19.4253453085366982
Ferrari5223454083387293115148169184
SL72234540833768
et80634540833961
al.8823454083375365
Childhood9633454083458398113152190228267306
fractures12853454083234578110135172194228255
are15553454083375892
associated16623454083376490128161176208230264303
with19813454083557193131
decreased212834540834378110132166198224259299
bone244234540834483121156
mass261334540836395122148
gain27773454083437590128
during4253554083397799115154193
puberty:63435540834584124160182207242256
an90535540833877
early9983554083397294110143
marker115635540836497119150185207
of137935540834362
persistent145735540834581103131146173197231270292
bone176535540834584124159
fragility?19403554083244780120136152167190225249
J2205355408329
Bone225035540834181120156
Miner242235540836076115151172
Res,261035540834177105118
2006;274435540834075112148161
21(4):4253654083346681114131143
p.58336540833951
501–507.65036540833468100133167201233239
20.4253753085367287
Greendale5273754083426397132170209242257292
GA83437540834183
et93237540833254
al.10013754083294558
Premenopausal10743754083335387145180218256296328366392425441
and153037540832967106
early16513754083326485100132
postmenopausal179837540833775102125183218256294334366404430463479
trabecular22923754083194073112148180218233265287
bone259437540833675113148
score27573754083245693114148
(TBS)4253854083195491124142
and58338540833472111
fracture7103854083214376108132170191225
risk:951385408323396595109
Study10763854083355694133165
of125638540834059
Women’s133138540836096154189228240265
Health161138540834479111126149187
Across18133854083447597134161187
the20153854083256398
Nation212838540834880102117155193
(SWAN).233738540832153111150195214225
Bone,257738540833877115150162
2020;275538540833670103137150
140:42539540833465101114
p.55539540833851
115543.6213954083346292124160192205
21.4254053085366981
Kužma5214054083326998156188
M724405408352
et79140540833153
al.8594054083294457
High9314054083425795133
Serum10794054083296485123180
Fractalkine12744054083304982114138170185215231269303
is159240540831238
Associated16454054083396692130163177209231264303
with19634054083486385123
Lower210140540832966117151172
Trabecular22884054083304779118153186223238270291
Bone259440540833371109143
Score27524054083306299120154
in42541540831552
Premenopausal4934154083325387144179217255295328365391424439
Women94841540835591149184222
with11854154083486386124
Graves’13244154083416396127161188201
Disease.15404154083435884119151177212224
HormMetab177941540834280101160227262284316355
Res,21504154083336794107
2018;22724154083326698128141
50(8):24284154083316585118136148
p.259141540833749
609–614.265541540833267102140177207238250
22.4254253085367288
Jackuliak5284254083296193123161176191223254
P797425408339
et85242540833860
al.9274254083365264
Good100742540834886125165
long-term11874254083195796135157179213234293
glycemic14954254083425889121154212228259
compensation177042540833572130169205243269303324340378416
is220142540831945
associated22624254083366289127160175207228262302
with25794254083557093131
better272542540834379101125159180
trabecular4254354083224375114150182219235267287
bone72843540833674112147
score8904354083245692114147
in105343540831249
postmenopausal111743540833675101124182217255293332364402428461476
women160843540834885143178216
with18394354083486385123
type19774354083195392128
22120435408331
diabetes.21664354083365183122157179212239252
Physiol243343540833370100127142180195
Res,26434354083336894107
2019;27654354083326697127140
68(Suppl4254454083347089120158197236252
2):6934454083345264
p.77244540833951
S149–s156.8394454083326394127164191221251286299
23.4254553085367287
Ross52845540833674101128
AC67145540834180
et76745540833456
al.8384554083324861
The91445540833372107
2011103745540833468100127
report11804554083215594133154179
on137445540833876
dietary14664554083385388110143164198
reference16804554083205574108129163202234267
intakes19634554083155274107137171198
for21764554083195778
calcium22704554083316479111126164222
and250745540833270109
vitamin26314554083324871103161176214
D2861455408345
from4254654083184078136
the5764654083266499
Institute6914654083195783106122144182205238
of94546540834160
Medicine:102146540835894133148180195233268281
what131746540835593126147
clinicians14804654083355065103118150165197235262
need175746540834277112152
to192446540832663
know.200246540833473112163174
J2191465408328
Clin22354654083445974112
Endocrinol236246540833775114152185206222260298314
M2691465408359
et276546540833861
al.28414654083365164
Effects4254754083335271105138162189
of63047540833958
the7044754083246297
bisphosphonate,8164754083415683122160198225264303341379412433467479
alendronate,13104754083345085123162183220258291313346358
on168447540833977
parturition17774754083417495119157178194217232270308
in210147540831654
the21714754083236297
rat.2283475408323567791
Toxicol23894754083356999115147184199
Appl260447540834382122138
Pharmacol,27574754083377510712842548540835790122159175187
1993;62748540833565100133144
121(2):7874854083346495110144162174
p.97648540833951
217–223.10434854083346595127159193228241
25.4254953085367287
Sokal52749540833170100134149
A692495408339
et74749540833356
al.8184954083304659
Pregnancy8924954083345589128166199237269302
and121049540833068107
newborn133249540833772123162201223261
outcomes16094954083367496127164222257284
after19084954083315075109130
exposure205349540833364104143169207228262
to233049540832057
bisphosphonates:24034954083375379118156194221260299337375408429463490502
a425505408332
case-control4725054083316491126149183219258279301338354
study.8415054083265088127159169
Osteoporos10255054083477497131170209248270307333
Int,1374505408315537487
2019;147750540833468100130143
30(1):16355054083346988120134146
p.179750540833851
221–229.186350540833469100133165200234245
26.4255153085367187
Cohen52751540834178117152190
A,73251540834256
Shane80351540833371104142177
E.99551540833346
Evaluation10575154083336598113151183205220258297
and136951540833270109
management149451540835890128161200235292327366387
of189651540833858
the19695154083226196
premenopausal20805154083396195153188226264304337375401434449
woman254551540835189147179217
with27785154083516789127
low42552540831553104
BMD.54452540833691137148
Current7075254083407798120154192213
osteoporosis9365254083376487120159199238259296323338364
reports,13155254083215594133155179207220
2013;155052540833569101130142
11(4):17075254083346277110127139
p.186252540833851
276–285.19285254083346799137169202236248
27.4255353085367281
Fink5225354083324886117
HA65553540834385
et75653540833356
al.8285354083314861
Long-Term90553540833169108148171201233255314
Drug123553540834467106146
Therapy139753540833171107129163203235
and164853540833169109
Drug177353540834567106146
Discontinuations19355354083446087120158197219235274312345368384422461488
and243953540833170110
Holidays25655354083438299115154187219246
for28275354083185679
Osteoporosis4255454083477599133172213252275312340355382
Fracture8235454083385892125150188210245
Prevention:10845454083406196129164203225241280319332
A1432545408346
Systematic14945454083336491115150208241264280312
Review.182254540834177110126161213225
Ann206354540834685123
Intern22025454083205981116138177
Med,239554540836095136149
2019;256054540833974107137151
171(1):272754540833969102118151166178
p.42555540833952
37–50.49355540833568101135170183
28.4255653085367187
Wotton52756540835590112136172210
CJ75256540833763
et83056540833153
al.8985654083294457
Use97056540834166100
of108556540833553
oral11535654083355688103
bisphosphonates12715654083365177115153191217256294331369401422455482
and176856540832966105
risk1888565408318335988
of199156540833453
hospital20595654083357399137152174207222
admission229656540832967124139165191205243280
with25915654083486385123
osteonecrosis2729565408334608311615442557540833771103124160187201226
of66657540833453
the7345754083195690
jaw:8395754083124494107
Large9605754083296182119154
prospective11285754083365793120158192224248263295328
cohort147157540832864102140161185
study16715754083234583121152
in183857540831249
UK190257540834075
women.199257540834784141176213226
Bone,223357540833270107141153
2019.24015754083316495125135
124:25515754083316192103
p.266957540833648
69–74.273257540833164101132161174
29.4255853085367185
Wood52558540835591129168
J708585408322
et74558540833153
al.8135854083294457
Novel88558540834280112145161
antiangiogenic10615854083296688103134172210225263302336374389421
effects14975854083315069103135159186
of169858540833554
the17675854083195791
bisphosphonate18735854083365277116154192218257295333371403424457
compound234558540832965123162200238275314
zoledronic267458540832663781131521732094255954083385385
acid.5255954083326479118131
J671595408324
Pharmacol71159540833572105126184217249286302
Exp102859540833265105
Ther,114859540833272107128138
2002;130159540833468104137150
302(3):146659540833469102119153170182
p.166359540833951
1055–1061.172959540833566100133169200231267297307
30.4256053085367389
Taxel5296054083396799134150
P694605408341
et75160540833962
al.8296054083375366
Cancer91060540834679118151185207
Treatment-Induced11326054083385690123145204240278300320337376415453486520560
Bone170860540834180119155
Loss187860540833775102129
in202360540832059
Women2097605408363100159195234
With234660540836480103142
Breast25036054083416398130157181
Cancer269960540834679118151185206
and42561540833270109
Men54961540835590128
With6926154083587496134
Prostate8426154083355593119143175197231
Cancer.108861540834073111143177198208
Journal131261540832462100121160192208
of153561540833757
the16076154083226095
Endocrine171761540833370109148180202217255290
Society,202261540833371104119154176210219
2018;225761540833468100131143
2(7):24156154083355286106118
p.254861540833951
574–588.26156154083346798135169203238252
31.4256253085366880
Gnant52062540834179111149170
M705625408352
et77262540833153
al.8406254083294457
Adjuvant9126254083387691128160193231252
endocrine117962540833169107145177198214251286
therapy14806254083195791112145183214
plus17096254083365289115
zoledronic18396254083256278112151172209247262293
acid21486254083296075114
in227762540831249
premenopausal23416254083365891149183221259298330368394426441
women27976254083488542563540835792130
with5706354083486486124
early-stage7096354083326384100132154180203236275310
breast10346354083365891123150173
cancer:12226354083296199131165186199
62-month14376354083316585143181220241279
follow-up1731635408316547085122173195234273
from20196354083163875133
the21686354083195792
ABCSG-12227563540833874114148192216246276
randomised25666354083185189128166224239265300339
trial.425645408322435991106119
Lancet55964540833265103135169191
Oncol,76664540834785117154170183
2011;96464540833468100128136
12(7):11156454083346482116136148
p.127864540833951
631–641.13446454083356899132169206236246
32.4256553085367186
Hershman5276554083427799126164221254292
DL83465540834375
et92565540833254
al.9946554083304558
Prevention10676554083335488120155193214230268306
of138865540833555
bone145865540833775114149
loss16226554083135178104
by174265540833667
zoledronic18256554083266379114153174212250265297
acid21376554083306277116
in226865540831351
premenopausal23346554083375892150185223262301334372398431447
women27966554083488642566540835792130
undergoing57166540833573112147168206244260298337
adjuvant9236654083306984122154187225247
chemotherapy118566540832967102160198220258293315348387418
persist16186654083377294121136162185
up181866540833574
to190866540831956
one197966540833674109
year21036654083296395116
following2235665408316536984123174189227266
discontinuing25166654083365278110147185207222260298313351390
treatment.4256754083224377109131189224262284297
J737675408324
Clin7776754083405570108
Endocrinol90067540833370109148180201217255293309
Metab,122567540835489111144183195
2010;143667540833468100131144
95(2):15956754083356986120138150
p.176067540833952
559–566.18276754083346799136170205240253
33.3047553085367186
Delmas3148554083448095153185212
PD33755540833479
et34695540833355
al.3540554083304659
Bisphosphonate3614554083344975114153191218257295334372404426460
risedronate408955408320356196136157194233265287320
prevents4425554083375993125159197219247
bone46875540833776115150
loss4852554083145278105
in49725540831452
women50395540834987145180218
with5273554083496587125
artificial541455408330517691304765408317346681113128
menopause31916540835893131170209242280306341
due35476540834077112
to36746540832360
chemotherapy37496540833371106164202224262297318351390422
of41866540833858
breast4259654083406195127154177
cancer:44516540833366104136169191204
a467165408333
double-blind,47196540833876114153169204227267283298336375388
placebo-controlled5122654083405688120154193232255289326364386304775408321587489124163
study.3226754083264987126158168
J340975408324
Clin3449754083405570108
Oncol,35727540834786118155171183
1997;37707540833465100133142
15(3):3928754083346482115132144
p.40887540833851
955–962.41547540833468101137172207241253
34.3047853085367388
Hines3151854083435896131158
SL33248540833162
et34028540833254
al.3472854083304558
Phase35468540833371103129164
III3726854083132844
randomized,3785854083195290129167226241270304343356
placebo-controlled,4156854083385486118152191230253287324362384405442458473508548560
double-blind47328540833674113152168202226266281296334373
trial512185408320415789104
of52418540833555
risedronate5311854083193561961351571943047954083387092125
for3188954083195678
the3281954083236196
prevention3392954083406195128162200222237275313
of37219540833857
bone37939540834079117152
loss3961954083155380107
in40839540831553
premenopausal4152954083396195153188226264304337374401434449
women46169540835290148183221
undergoing48529540833876115150172210248263301340
chemotherapy5208954083327010516220122326129630471054083215493124
for31861054083195678
primary32791054083396176134166187221
breast35161054083386094126152176
cancer.370710540833164102134168189199
J3922105408324
Clin39611054083405570108
Oncol,408510540834785117154170183
2009;428310540833468104139152
27(7):44511054083346783118137149
p.461510540833952
1047–1053.468210540833465102134166197229263296308
35.30471153085367186
Bone314811540834179118153
HG331611540834994
et342511540833961
al.35021154083375265
Effects35821154083385776110143167195
of379211540834262
Denosumab386911540835186124162189226284317356
on424011540834281
Bone433611540834179118153
Mineral450411540836075113148169202218
Density473711540835086124150165187221
and497411540833674113
Bone510311540834079117152
Turnover52711154083377192130169201235256
in304712540831553
Postmenopausal311512540833874101124182217255294333366404430463479
Women.360912540836096155190228241
The386512540833575110
Journal399012540832765103124163195211
of421612540834059
Clinical42901254083435873111126158191206
Endocrinology451112540833573112150183204220258296312350390422
&4948125408342
Metabolism,500512540835792115147187225241256282340353
2008;537312540833771107142155
93(6):30471354083346785118136148
p.321113540833851
2149–2157.32771354083346697130167199230260294300
36.30471453085357186
Finkelstein31481454083294481110144159184206239254291
JS345414540832152
et352114540833152
al.35881454083294456
Prevention36591454083325285117150188208223260298
of397214540833452
estrogen40391454083315780101137176210247
deficiency-related43011454083356986102134148182219251283305326359375406427460499
bone481414540833674112146
loss49741454083125076102
with50901454083486384122
human522714540833471127159196
parathyroid54381454083356830471554083205374112142164201216254
hormone-(1-34):33161554083357394152190228262285305336354386421438450
a3781155408329
randomized38251554083215391129167225239268302341
controlled418115540832865103124145182197212246286
trial.4482155408318405586102114
Jama,461115540832253111142155
1998;47811554083316196131143
280(12):49391554083316499118149179197208
p.516215540833648
1067–1073.52251554083326398130162193224256290302
37.30471653085367079
Cohen314116540833774112147185
A3341165408338
et339416540833456
al.34651654083294457
Teriparatide3537165408330618297136168189222244259297332
for38841654083165374
idiopathic39731654083135166104143176197235250281
osteoporosis42691654083356184118156195234255292319333359
in464316540831250
premenopausal47081654083365791148183221259298331368394427442
women:516516540834885143178216228
a5408165408329
pilot54521654083395430471754083155375
study.31371754083264987126158168
J3321175408324
Clin33601754083405570108
Endocrinol348317540833371110148181202218256294310
Metab,380817540835590112145184196
2013;401917540833469100130142
98(5):41761754083346988122140152
p.434317540833951
1971–1981.44101754083346497129162193223258290300
38.30471853085367389
Choe315118540834684122158
EY332418540833876
et341518540833962
al.34921854083375366
Effect35731854083385776111144168
of375718540834262
teriparatide3834185408327618298137171192225247262302337
on418618540834381
pregnancy428318540834466100140178210249281315
and461318540833776115
lactation-associated47431854083205385109142164180218257279312339365404437452484506540580
osteoporosis5338185408343709312716630471954083397799136163178204
with32661954083516689127
multiple340819540835895111133148187203238
vertebral36621954083316587111145184206239254
fractures.39321954083184073105129167188222249263
J4210195408324
Bone425019540833574112147
Miner441219540835570108143164
Metab,459219540835489111144183196
2012;480319540833468100130142
30(5):49601954083356989122141153
p.512819540833851
596–601.519419540833467102140177213245254
39.30472053085367185
Langdahl314720540833669108147186218256271
BL343420540833971
et352120540833860
al.35972054083365164
Teriparatide36762054083376889105144177198231253268307342
versus40332054083367192119156183
alendronate42312054083365186124163185222260293314348
for45942054083236182
treating46922054083264781113135150188227
glucocorticoid-induced49342054083435895128164197234256280296328364380419441457495534572304721540833165104
osteoporosis:31672154083416891125164203242264301328343369381
an356421540833674
analysis365321540833674107122154181196222
by389021540834375
gender398021540834277115155189211
and420621540833674113
menopausal433521540836196135173212245283309342358
status.47082154083315487108146173186
Osteoporos491021540835178101135174213252274311338
Int,5263215408319577992
2009;537021540833973109144157
20(12):30472254083346888119149167179
p.324222540833851
2095–2104.330822540833468103138174205237268305317
40.30472353085367489
Curtis31512354083407697122137163
JR333023540832359
et340423540833456
al.34752354083314760
Population-based355023540833471111149164196218234272310332372405432467506
assessment40722354083315784119146172230265303325
of441223540833756
adverse448323540833170103137159186221
events471923540833366100138160187
associated49222354083315784122155170202224257297
with52342354083506688126
long-53762354083145290129152
-term3047245408321437798157
glucocorticoid32192454083385391123160193230251276291323360375414
use.36492454083376398110
Arthritis37752454083416286125146161184199225
Rheum,401624540833573108146204217
2006;424824540833468104140152
55(3):44162454083346684118135147
p.457824540833951
420–426.464424540833567101139176209242256
41.30472553085366881
Rizzoli31432554083334978109146162177
R,333625540833346
Biver33982554083334881115136
E.354925540833144
Glucocorticoid-induced36082554083415795127164196233255280295327364379418440456494533570603636676
osteoporosis:42992554083356285118157197235257294321336362374
who468925540834886124
to482925540831956
treat49002554083204175107129
with50442554083486486124
what518425540834886118140
agent?534025540832968103141162188
Nat30472654083457799
Rev316126540833570103
Rheumatol,327926540833574109147204237258295311324
2015;361826540833468100130141
11(2):37742654083346277111129141
p.393026540833951
98–109.399726540833469106137168203214
42.30472753085367085
Payer31472754083326494128149
J,331127540832133
Brazdilova33592754083325386115152167182219251283
K,365727540833246
Jackuliak37182754083225385115152167182213243
P.397627540833237
Management402827540835183121152191225282317354375
of441827540833554
glucocorticoid-induced44872754083355087118154187223244268283315351366404426442479517554586619658
osteoporosis:51602754083346183116155194232253290316330356368
prevalence,30472854083396094127160175210248280314326
and338828540833169108
emerging351128540833391126147185201238277
treatment38042854083204276108130188223261282
options.41022854083367698113151189216229
Drug434728540834466104143
Healthc450528540834378110126148186218
Patient47392854083346688103137176197
Saf,4951285408332658495
2010;50612854083336799130143
2:522028540833345
p.528128540833750
49–59.534628540833367104138170181
43.30472953085367186
Van314829540834071109
Staa32732954083365790122
TP341129540833673
et349929540833860
al.35752954083365164
Use365429540834874109
of377829540834161
oral38542954083416396111
corticosteroids39802954083367394119134166203230253287308345361399426
and442129540833674113
risk4549295408325406796
of466129540834160
fractures.47372954083224477109133171193227254267
J5019295408329
Bone506329540833978116151
Miner523029540835873111146168
Res,541329540833974101114
2000;304730540833468104140153
15(6):32163054083346482115133145
p.337630540833951
993–1000.344330540833469102138169200237273285
44.30473153085367490
Miller31523154083577288103138159
KK332631540833774
et341531540833658
al.34893154083344962
Determinants356631540834883105139160219234272304342364391
of397331540833958
skeletal40473154083285892108143165198213
loss42753154083175582109
and439931540833472111
recovery45253154083235790127159193214248
in478931540831754
anorexia485931540833472110132166197213245
nervosa.51193154083407596131168195228241
J5376315408326
Clin54173154083435873111
Endocrinol304732540833370109148180202217255293309
Metab,337232540835489111144183195
2006;358332540833468104140152
91(8):37513254083346681114132144
p.391132540833851
2931–2937.397732540833468101132165197231264296302
45.30473353085367186
Tichá31483354083335082120152
Ľ3315335408332
et336233540833457
al.34343354083324760
Porucha35103354083357293131164202234
kostného37593354083306794117156191229267
metabolizmu404133540835893115148187226242257286344382
pri44383354083396176
mentálnej453033540835792130152185200238273288
anorexii483333540833270109130164196211226
Čes-slov507533540834074100121148164202234
Pediat.,532433540833569108123155177190203
2016;304734540833468100131143
71(5–6):32063454083346681115151189207219
p.344034540833951
287–292.350634540833568101134165199233245
46.30473553085367489
Sim315235540833549107
LA327435540833477
et336635540833658
al.34403554083334962
Effect35173554083355372107140164
on369635540833978
bone378935540834079118153
health395735540833974106122144182
of415535540833958
estrogen42283554083366386108145184219257
preparations45013554083406296135168189222244259297336362
in487835540831755
premenopausal49483554083416296154189227266305338376402435451
women541435540835290304736540835792130
with31923654083486486124
anorexia333136540833068106127161193208240
nervosa:35863654083357091126163190223235
a3836365408330
systematic38813654083265885108142200232254269301
review41973654083185284100134185
and439836540832967106
meta-analyses.451936540835590112144167199237269284316343378404418
Int49523654083135072
J5039365408322
Eat50763654083306385
Disord,51763654083435884122144182194
2010;53863654083316597128141
43(3):30473754083346785118136147
p.321037540833851
218–225.32763754083346697134165200235247
47.30473853085367079
Baqi314138540833770109124
L3280385408333
et332838540833658
al.34013854083334961
Thyrotropin347838540833473104125163185206243283298336
versus38303854083336788115153179
thyroid40243854083236192114151166205
hormone42453854083387798157195234269
in452938540831654
regulating45983854083225696133148181202218256295
bone490838540834079117152
density507538540834075113139154176210
and530038540833472111
turnover54263854083236182304739540833876108142163
in322639540831452
premenopausal32933954083396195153188226264304337374401434449
women.375739540835189147182220233
Endocr400639540833270109147180201
Regul,422339540833570109147162175
2010;441339540833468100132144
44(2):45733954083347190124142154
p.474239540833952
57–63.480939540833467100137171183
48.30474053085367389
Kuzma31514054083337099157189
M,335640540835165
Payer34364054083336495129150
J.360240540832134
(Growth36514054083165980117168193231
hormone38974054083357395153191229264
deficiency,41764054083367188105137152187224257290300
its44914054083123462
influence4568405408312506784122156194226260
on484340540833573
bone493140540833775114148
mineral509540540835570107142163196211
density532240540833570108134149171205
and304741540833270109
risk3171415408321366392
of327941540833756
osteoporotic33514154083376487121159199238259296318334366
fractures).37324154083184073106130168189223250267278
Cas40254154083407399
Lek41404154083316596
Cesk,425141540834074100130145
2010;441141540833469100132145
149(5):45714154083346598117151169181
p.476841540833851
211–216.48344154083346693126158189220234
49.30474253085367285
Kužma314742540833471100158191
M3353425408353
et342142540833355
al.34914254083314659
(Issues3565425408317325885122157184
related37644254083195369101123157196
to397542540832158
secondary40484254083245992129167207239260294
osteoporosis43574254083366386120158198237258296322337363
associated47364254083305683121154169201223256296
with50474254083496587126
growth51884254083365895146171209
hormone54124254083367496304743540835796134169
deficiency32314354083397391108140155190228260294
in354043540831552
adulthood).360843540833271108123146184222261301320331
Vnitr39544354083367388111132
Lek,41024354083316595110
2017;422743540833469100130140
63(10):43824354083346886117149167179
p.457743540833851
658–661.464343540833468102139176212242252
50.30474453085367287
Kužma31494454083337099157189
M3353445408352
et342044540833254
al.34894454083294558
Impact356244540831270109141173197
of377544540833454
the38444454083195792
growth39514454083365794145169207
hormone41734454083357395153191229264
replacement44524454083195392107139171205263298335357
on482444540833573
bone491244540833675113148
status50754454083244780101139165
in525544540831350
growth53214454083355693144169207
hormone30474554083387697156194233268
deficient33304554083387390107140155189227249
adults.359445540833271109124146174188
Growth379745540834465103154178216
Horm402945540834482104162
IGF42064554083156093
Res,43144554083357097110
2014;444045540833468100131143
24(1):45984554083346685117132143
p.475745540833851
22–28.482345540833469103135169182
51.30474653085367082
Kužma314446540833572102160192
M3352465408354
et342146540833457
al.34934654083324760
Kvalita35684654083356598113128151183
kosti37674654083296794117132
u3914465408337
akromegalikov.39674654083326284121180215254287302317347384416426
Vnitřní44094654083357288110131170185
lékařství,46094654083155080114135162185219235248
2017;487246540833468100130139
63(9):50274654083346886118136148
p.519046540833951
589–592.525746540833468102140174206239252
52.30474753085367187
Kužma315047540834178108166199
M3364475408360
et344047540833962
al.35174754083375366
Trabecular35984754083385689129164197235251283305
Bone391847540834180119154
Score408747540833871108130164
Change426747540834583116154193229
Differs45114754083516786106140162189
with47164754083567194133
Regard486447540834176116149170208
to508847540832764
25(OH)D51684754083397492139184203249
Levels54334754083377130474854083326682108
in317048540831856
Patients32414854083387092107142180202229
Treated34864854083355387118140174214
for37154854083215981
Adult-Onset381148540834482120135158177227266292327350
Growth417648540834768106157181220
Hormone441148540834785107166204242277
Deficiency.470448540834883101118150165200238270304314
Endocrine503348540833674113151183205220258293
Practice,5342485408338599212414816330474954083316577
2016;313949540833468100131144
22(8):32984954083346986120138150
p.346349540833951
951–958.35304954083346899132167201235248
53.30475053085367186
Kužma314850540833573102160192
M3356505408354
et342650540833456
al.34975054083324861
Non-invasive357350540834583121144160198229262289303336370
DXA-derived395950540834582125146187222243259291325365
bone433950540833978116151
structure45065054083264971109141165203224258
assessment47805054083325885120147173231266304325
of512150540833756
acromegaly51935054083326485122181216255288303335
patients:30475154083397293109143181203231243
a3306515408331
cross-sectional33535154083315289116143164191226258282298336374406422
study.37905154083264987126158168
Eur39745154083326990
J4079515408324
Endocrinol,411951540833270109147180201217255293309321
2019;445651540833468100130143
180(3):461451540833465101120154171183
p.481251540833951
201–211.487951540833468100132164196223233
54.30475253085367388
World315052540835793115131169
Health,333552540834378110125147186198
O.,35495254083465770
Guideline:36345254083438196135170186200238273286
calcium39355254083306379111126163221
supplementation417152540832563102141157192250285323345377399415452491
in467752540831452
pregnant47445254083385993133171203241263
women.502252540835087146181219232
2013,52695254083336799129141
Geneva:542652540834278304753540833873105138150
World321253540835894116132170
Health339853540834479111126149187
Organization.360053540834769107139177192221255277292330368382
55.30475453085357084
Holick31465454083417994109140169
MF333054540835284
et342954540833153
al.34965454083294457
Evaluation,35685454083296093107144176197212249287299
treatment,38825454083194073104126183217254275288
and418554540832966105
prevention43045454083365790122156193214229266304
of462354540833453
vitamin4691545408328446598154169206
D4912545408342
deficiency:49695454083356987103135149183221252285298
an528254540832966
Endocrine53635454083306710514230475554083315268106141
Society320355540833068101116150172206
clinical3424555408329445997112144177192
practice36315554083365891123147162194228
guideline.38745554083367388127162177192230265277
J4166555408322
Clin42035554083385368105
Endocrinol432455540833067106144177198214252290306
Metab,464555540835287109142181193
2011;48535554083326697125133
96(7):50015554083326886121140152
p.516855540833749
1911–1930.52325554083326294122155185215248282295
56.30475653085367187
Kalkwarf31495654083326580110162195215236
HJ340056540834266
et348156540833153
al.35495654083294457
The362156540833068103
effect37395654083315069103135159
of391356540833453
calcium39815654083286176107122159216
supplementation42125654083236099138153188245279317338370392407444482
on470956540833472
bone479656540833674112147
density495856540833569107133147169202
during51755654083367393109146184
lactation5374565408313447610013230475754083223775113
and317657540833169109
after33005754083325176109131
weaning.344657540835085117155170208247260
N3721575408345
Engl378157540833371110125
J3921575408324
Med,396157540835489129141
1997;41185754083346499132142
337(8):427557540833568100116150168180
p.447057540833951
523–528.453657540833568102139173206240253
57.30475853085367079
Scioscia31415854083306277114141173187219
MF337558540835284
et347458540833254
al.35435854083294457
Severe36155854083306496130151185
Bone381558540833270108143
Microarchitecture39735854083526798119156189210240278293315348380404442463496
Impairment448458540831370109141156177235269307328
in482758540831250
Women489258540835491148183221
With51285854083547092130
Pregnancy52735854083325387126163195233304759540833165
and312759540833270109
Lactation-Associated32515954083326597121154176191229268290331359386424457472504526559599
Osteoporosis.38655954083477497131170209248270307334349375388
J4269595408324
Endocr430859540833370110148180202
Soc,452559540833271103116
2021;465759540833468101132141
5(5):48135954083345285104116
p.494459540833951
bvab031.501059540833971104143179212243253
58.30476053085367288
O’Sullivan31506054083455891129144159174206239277
SM344260540833084
et354260540833153
al.36106054083304558
Bisphosphonates36836054083334874113151190216255293331370402424457484
in418260540831250
pregnancy42476054083375892131169201239271305
and456760540832967106
lactation-associated46886054083134577101133155170208246269301327354392424439471493527566
osteoporosis.526960540833562851181571962353047615408321588599126139
Osteoporos32016154083477498131170210249270307334
Int,3550615408315537588
2006;365361540833468105140153
17(7):38216154083346380114134146
p.398261540833951
1008–1012.404961540833465101137174205236268298310
59.30476253085367184
Cerit314662540834579101116139
ET,33006254083387382
Cerit339762540834579100116139
M.355162540836074
A3640625408346
case37016254083326591126
of384362540834262
pregnancy39206254083446599139177210248280313
and424962540833775114
lactation43786254083205385109142164179217256
associated46496254083376390128161176208230264304
osteoporosis49686254083426992126165205244265303329344370
in535462540832057
the542762540832765100
third3047635408322607596134
pregnancy;319663540834466100139177210248280313326
robust353863540832563102140167190
response37436354083266087126165203229264
to402363540832663
teriparatide4102635408326608197136169190223245260299334
despite445163540834378105144159182215
delayed46826354083437893126156191230
administration.492863540833675133148186201227251272305327342380418432
Bone537563540834079117152
reports,30476454083215594133154179207220
2020;328264540833468101135148
13:34456454083356576
p.353664540833951
100706–100706.360364540833465101134167203241272303339372405441454
60.30476553085367388
Recker315165540833671103133168189
RR335565540833572
et344265540833456
al.35146554083324760
Bone358965540833674112147
gain37526554083387085123
in389165540831452
young395865540833169107145184
adult415765540833271109124146
women.431965540835088146181219233
Jama,456765540832456114146159
1992;47426554083346499132145
268(17):490265540833468103122154183203215
p.513265540833951
2403–2408.519965540833466102135171203235271306319
61.30476653085366981
Peris31436654083397294109135
P3294665408338
et334766540833860
al.34226654083355164
Bone350166540833977116151
mineral366766540836176114149170203218
density390166540834176114140155178211
evolution412866540833769107123160183198236275
in441866540831856
young448966540833472110148187
premenopausal46916654083426498156191229267307340378404437452
women515966540835491150185223
with53976654083547092130
idiopathic30476754083155369107146179201239254286
osteoporosis.33486754083386488121160200238260297324339365379
Clin37426754083405570108
Rheumatol,386567540833574109147204237259295311324
2007;420467540833468104137147
26(6):43666754083346887120138150
p.453167540833952
958–961.459867540833468102139174210240249